Global Submucosal Injection Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Submucosal Injection Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.

It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.

According to our (Global Info Research) latest study, the global Submucosal Injection Agent market size was valued at US$ 108 million in 2023 and is forecast to a readjusted size of USD 178 million by 2030 with a CAGR of 7.5% during review period.

The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.

This report is a detailed and comprehensive analysis for global Submucosal Injection Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Submucosal Injection Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Submucosal Injection Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Submucosal Injection Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Submucosal Injection Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Submucosal Injection Agent

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Submucosal Injection Agent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, The Standard, Micro-Tech Endoscopy, EndoClot Plus, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Submucosal Injection Agent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Syringe Type
Ampoule Type

Market segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Major players covered
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Submucosal Injection Agent product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Submucosal Injection Agent, with price, sales quantity, revenue, and global market share of Submucosal Injection Agent from 2019 to 2024.

Chapter 3, the Submucosal Injection Agent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Submucosal Injection Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Submucosal Injection Agent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Submucosal Injection Agent.

Chapter 14 and 15, to describe Submucosal Injection Agent sales channel, distributors, customers, research findings and conclusion.